research alliance
Perthera, Side-Out Foundation Partner to Advance Precision Oncology in Breast Cancer
The partners will use Perthera's AI platform to match advanced breast cancer patients to targeted treatments and clinical trials based on tumor profiling.
Heligenics, Jackson Lab Partner to Study Breast Cancer Gene Variants
Heligenics will apply its GigaAssay, a massively parallelized platform for assaying molecular functions of single cells in culture, to ERBB2 variants.
AstraZeneca, Alchemab Partner on Prostate Cancer Immunotherapy Research
UK-based Alchemab will use its platform to sequence the antibody repertoires of prostate cancer patients treated within an AstraZeneca immunotherapy trial.
BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker Research
The partners will look for patterns in patients' exome sequencing and transcriptomics data to try to predict treatment response.
Roswell Park, University of Rochester to Study Immunotherapy in Cancer Patients of African Ancestry
The Western New York-based institutions will assess molecular differences driving immunotherapy responses in Black versus white cancer patients.